KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 58 filers reported holding KRYSTAL BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $580 | -1.2% | 5 | 0.0% | 0.00% | – |
| Q2 2023 | $587 | +46.8% | 5 | 0.0% | 0.00% | – |
| Q1 2023 | $400 | -15.8% | 5 | -16.7% | 0.00% | – |
| Q4 2022 | $475 | -52.5% | 6 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -97.8% | 6 | -99.1% | 0.00% | – |
| Q4 2021 | $46,000 | -89.1% | 660 | -91.9% | 0.00% | -100.0% |
| Q3 2021 | $423,000 | -96.0% | 8,111 | -94.7% | 0.00% | -94.7% |
| Q2 2021 | $10,446,000 | +1.2% | 153,614 | +14.6% | 0.02% | -5.0% |
| Q1 2021 | $10,323,000 | +257975.0% | 133,991 | +107957.3% | 0.02% | – |
| Q1 2019 | $4,000 | -80.0% | 124 | -87.1% | 0.00% | – |
| Q4 2018 | $20,000 | +17.6% | 958 | 0.0% | 0.00% | – |
| Q3 2018 | $17,000 | – | 958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |